hydroxychloroquine has been researched along with African Lymphoma in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine if Rituximab coated Biodegradable Nanoparticles (BNPs) loaded with Chlorambucil and Hydroxychloroquine could induce apoptosis of B-Chronic Lymphocytic Leukemia (B-CLL), MEC-1 and BJAB cells in vitro and evaluate their toxic and therapeutic effects on a Human/Mouse Model of Burkitt Lymphoma at an exploratory, proof of concept scale." | 3.76 | Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. ( Ingrao, S; Larsen, G; Maceira, A; Macor, P; Mansilla, E; Marín, GH; Mertz, C; Mezzaroba, N; Núñez, L; Spretz, R; Tau, JM; Tedesco, F; Tripodo, C; Zorzet, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marín, GH | 1 |
| Mansilla, E | 1 |
| Mezzaroba, N | 1 |
| Zorzet, S | 1 |
| Núñez, L | 1 |
| Larsen, G | 1 |
| Tau, JM | 1 |
| Maceira, A | 1 |
| Spretz, R | 1 |
| Mertz, C | 1 |
| Ingrao, S | 1 |
| Tripodo, C | 1 |
| Tedesco, F | 1 |
| Macor, P | 1 |
1 other study available for hydroxychloroquine and African Lymphoma
| Article | Year |
|---|---|
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; B-Lymphocytes; Burkitt Lymph | 2010 |